Clinical Trial Update: Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant capecitabine and oxaliplatin versus standard follow-up care after surgery for locally advanced rectal cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Cancer Research UK | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED